Cdc7-IN-5

CAT: 0804-HY-130517-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-130517-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Cdc7-IN-5 (compound I-B) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-B. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle[1].
CAS Number
[1402057-86-6]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdc7-in-5.html
Concentration
10mM
Purity
96.73
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C(C/1=O)=C(N2CC3=C(C=CC(OC)=C3)CC2)OC1=C/C4=CNC5=NC=CC=C54)OCC
Molecular Formula
C25H23N3O5
Molecular Weight
445.47
References & Citations
[1]Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-143433Cdc7-IN-19
HY-143431Cdc7-IN-17
HY-143432Cdc7-IN-18
HY-101523-01Cdc7-IN-1
HY-143387Cdc7-IN-13
HY-117677-01Cdc7-IN-21
HY-130519Cdc7-IN-7
HY-143383Cdc7-IN-11
HY-143385Cdc7-IN-12
HY-143377Cdc7-IN-8

Alternative Products

CatalogName
MBS5766300Cdc7-IN-5
310131CDC7
bsm-61146R-Cy5.5CDC7 Recombinant Antibody, Cy5.5 Conjugated
TS425969P5CDC7 CytoSection
MBS5803155Cdc7-IN-15
MBS5766298Cdc7-IN-3
MBS5803536Cdc7-IN-9
E046446CDC7 Antibody
BUP01896-01Cdc7-IN-7
bs-5148R-Cy5.5Cdc7 Polyclonal Antibody, Cy5.5 Conjugated

Popular Products